OCX - OncoCyte Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

OCX is currently covered by 3 analysts with an average price target of $21.38. This is a potential upside of $18.22 (576.58%) from yesterday's end of day stock price of $3.16.

OncoCyte Corp's activity chart (see below) currently has 50 price targets and 45 ratings on display. The stock rating distribution of OCX is 85.71% BUY and 14.29% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 42.41% with an average time for these price targets to be met of 63.55 days.

Highest price target for OCX is $8, Lowest price target is $4, average price target is $5.42.

Most recent stock forecast was given by THOMAS FLATEN from LAKE STREET on 20-May-2025. First documented stock forecast 23-Mar-2016.

Currently out of the existing stock ratings of OCX, 6 are a BUY (85.71%), 1 are a HOLD (14.29%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$8

$4.84 (153.16%)

$5

5 months 7 days ago
(20-May-2025)

1/6 (16.67%)

$4.93 (160.59%)

204

Buy

$4.25

$1.09 (34.49%)

$4.25

5 months 15 days ago
(12-May-2025)

2/11 (18.18%)

$1.48 (53.43%)

58

Hold

$4

$0.84 (26.58%)

$25

7 months 2 days ago
(25-Mar-2025)

1/2 (50%)

$0.82 (25.79%)

16

Buy

$5

$1.84 (58.23%)

$5

1 years 6 months 13 days ago
(14-Apr-2024)

0/4 (0%)

$2.47 (97.63%)

Hold

$3

$-0.16 (-5.06%)

$3.5

1 years 11 months 15 days ago
(12-Nov-2023)

2/5 (40%)

$0.24 (8.70%)

2

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is OCX (OncoCyte Corp) average time for price targets to be met?

On average it took 63.55 days on average for the stock forecasts to be realized with a an average price target met ratio 42.41

Which analyst has the current highest performing score on OCX (OncoCyte Corp) with a proven track record?

PAUL KNIGHT

Which analyst has the most public recommendations on OCX (OncoCyte Corp)?

Paul Knight works at KEYBANK and has 9 price targets and 6 ratings on OCX

Which analyst is the currently most bullish on OCX (OncoCyte Corp)?

Mark Massaro with highest potential upside - $156.84

Which analyst is the currently most reserved on OCX (OncoCyte Corp)?

David Westenberg with lowest potential downside - -$0.16

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?